Cancer cells overexpressing ERCC1 were correlated with drug resistance to chemotherapy containing cisplatin, carboplatin, or oxaliplatin in several types of tumors such as gastric, bladder, ovarian, colorectal, and lung carcinomas [28]. The gene discussed is ERCC1; the disease is lung carcinoma.